This week I will be interviewing Prof Alex Crandon whose specialty is Surgical Gynaecologic Oncology and one of the few surgeons in the world practising Hyperthermic intraoperative intraperitoneal chemotherapy or HIPEC; a special type of surgery recommended for some women with ovarian cancer which promises to significantly improve survival. He was the first to introduce the method to Australia. When diagnosed with gynaecological cancer there are not only decisions to be made about a potentially life-threatening illness but the biggest challenge for a woman is also the morbidity factor; life qu
|